Vivex Biologics develops and delivers biologic and regenerative health therapies. Learn more about our innovative allograft solutions.
Employees: 201-500
Total raised: $23.2M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | JAM Capita... | jamcapital... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 06.04.2017 | - | $9M | - |
| 05.01.2016 | - | $6.6M | - |
| 19.09.2013 | - | $7.6M | - |
Mentions in press and media 8
| Date | Title | Description |
| 15.07.2021 | Vivex Biologics, Inc. Launches VIA Mend™ Synthetic Bone Fillers | |
| 19.05.2021 | VIVEX Biologics, Inc. Launches New Family of Allografts, VIAGENEX™ | |
| 19.04.2017 | Onkos Surgical’s “specialty medtech” model attracts a $17.6M Series B | While it has some solid partnerships and a new $17.6 million Series B financing round under its belt, how can it possibly compete? The tactic, according to CEO Patrick Treacy, is specialization. Onkos isn’t taking on Goliath, it’s just taki... |
| 06.04.2017 | Vivex Biomedical Receives $9m Credit Line | Vivex Biomedical, Inc., an Atlanta, Georgia-based regenerative biologics company, received a $9m line of credit. Heritage Bank of Commerce, the operating bank of Heritage Commerce Corp (NASDAQ:HTBK), provided the financing. The company will... |
| 05.01.2016 | Vivex Biologics gets $6.6M for next-gen implant tech | It offers a number of products – such as AlloGen, an amniotic fluid therapy that’s full of growth factors and cytokines that help with wound healing, cell proliferation and tissue protection. Rather than viewing implants as simple support s... |
| 19.09.2013 | Vivex Biomedical Completes $7.6M Financing | Vivex Biomedical, Inc., a Marietta, GA-based biomaterials manufacturer and developer, completed a $7.6m first round of private equity financing. Backers remained undisclosed. The company intends to use the funds to refine current and develo... |
| - | Onkos Surgical’s “specialty medtech” model attracts a $17.6M Series B | It’s an interesting take on the David vs. Goliath battle. Founded in 2015, Parsippany, New Jersey-based Onkos Surgical is trying to penetrate an orthopedic device market dominated by industry giants such as Stryker and Biomet. While it has ... |
| - | Vivex Biologics gets $6.6M for next-gen implant tech | Georgia-based Vivex Biologics is developing a suite of bone and tissue implants – offering grafts and fillers that help with spinal fusion and void filling. The startup is in the midst of a $10 million fundraise, having brought in $6.6 mill... |